Call for papers for International Journal of General Medicine: Innovations and Integrations in Regenerative Medicine
The International Journal of General Medicine is currently inviting submissions for its latest Article Collection titled ‘Innovations and Integrations in Regenerative Medicine’.
Regenerative medicine is increasingly recognized as a central pillar of future healthcare. Unlike conventional treatments that primarily focus on managing symptoms, regenerative approaches aim to restore or replace damaged tissues and organs. This shift is particularly important as chronic diseases, degenerative conditions, and organ failure continue to increase in prevalence worldwide. Advances in stem cell biology, biomaterials, tissue engineering, gene editing, and immunomodulation are driving progress toward therapies that have the potential to provide lasting functional recovery. This Article Collection, “Innovations and Integrations in Regenerative Medicine” aims to present recent developments that demonstrate scientific discoveries and how they are being translated into clinical practice. By bringing together contributions from basic science, translational research, and clinical studies, the series highlights the potential of regenerative strategies to redefine treatment pathways and set new standards of care in modern medicine.
Regenerative medicine tackles health problems that current treatments often fail to resolve. Chronic conditions such as heart disease, diabetes, neurodegenerative disorders, and organ failure are typically managed, not cured. Regenerative approaches seek to restore the structure and function of damaged tissues and organs, directly addressing root causes rather than symptoms. This field promises to overcome critical limitations like organ transplant shortages and immune rejection by enabling growth or restoration of tissues using a patient’s own cells. It also holds cross-cutting potential for different targets, such as cardiovascular repair, neurological disorders, autoimmune diseases, and more. There are many of these therapies have already reached clinical or commercial stages, including FDA-approved treatments for wounds and orthopedic injuries, strengthening the path from research to real-world impact.
This Article Collection centers on regenerative medicine within the framework of internal medicine, reflecting the journal’s commitment to enhancing understanding of pathogenesis, diagnosis, treatment protocols, patient outcomes, and quality of life. It welcomes contributions that explore areas such as stem-cell therapies, biomaterial innovations, tissue engineering, gene editing, immune modulation, and their clinical applications in cardiovascular, endocrine, neurological, and multi-system diseases. Articles that integrate basic research and clinical trials are especially welcome.
Please review the journal Aims and Scope and Author Guidelines prior to submitting a manuscript. The deadline for submission is 6 July 2026.
If you are interested in contributing or would like to learn more, please reach out to the Commissioning Editor Francis Straw ([email protected]).